Proinsulin ELISA

(10-1118-01)

Kit format: 1 x 96 wells

Measurement range: 3.3 - 130 pmol/L (0.03 - 1.18 µg/L)

Measures total proinsulin

CE/IVD labeled on select markets

Highly specific with no cross-reactivity to human insulin or C-peptide

Calibrated against International Reference Reagent IRR 84/611 for human proinsulin

Serum controls available: 10-1134-01 (US only) or 10-1164-01

TALK TO A PERSON

Description

The Proinsulin ELISA is a method for the quantitative determination of human proinsulin in serum or plasma.

The Mercodia Proinsulin ELISA is a highly specific tool registered for in vitro diagnostics (IVD) use. It is calibrated against International Reference Reagent IRR 84/611 for human proinsulin. The specificity of the utilized antibodies enables measurement of human proinsulin without interference from insulin or C-peptide.

Each Mercodia Proinsulin ELISA kit contains reagents for 96 wells, sufficient for 42 samples and one calibrator curve in duplicate. The microplate strip format (12 strips x 8 wells) is ideal when only a limited number of samples need to be analyzed.

Mercodia Diabetes Antigen Control (10-1134-01 (US only) or 10-1164-01) is designed to be used as a two-level control for human proinsulin.

Test characteristics

Species

Human

Samples

Serum and plasma

Sample volume

50 µL

Assay range

3.3 - 130 pmol/L (0.03 - 1.18 µg/L)

Detection limit

≤1.7 pmol/L

Incubation

1 h + 1 h + 15 min

Detection method

Absorbance

specificity

The following cross-reactions have been tested:

Insulin

< 0.03 %

C-peptide

< 0.006 %

Proinsulin (Des 31-32)

95 %

Proinsulin (Split 32-33)

95 %

Proinsulin (Des 64-65)

84 %

Proinsulin (Split 65-66)

90 %

Porcine Proinsulin

4 %

Mouse Proinsulin I

3 %

Mouse Proinsulin II

16 %

Rat Proinsulin I

13 %

Rat Proinsulin II

10 %

directions for use Certificate of Analysis Safety Data Sheet

directions for use

LOT. NO.	DOCUMENT
35902	DfU - 10-1118-01 v. 21.0
35639	DfU - 10-1118-01 v. 20.0
35327	DfU - 10-1118-01 v. 20.0

Certificate of Analysis

LOT. NO.	DOCUMENT
35902	CoA - 10-1118-01
35639	CoA - 10-1118-01
35327	CoA - 10-1118-01

Safety Data Sheet

DOCUMENT
SDS - 10-1118-01

For other languages and previous versions: Technical Library

references

Fraser, A. et al. (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125, 1367–1380. Read more >

AlEssa, H. B. et al. (2017) Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women. Am. J. Clin. Nutr. 105, 432–441. Read more >

Velazco-Cruz, L. et al. (2019) Acquisition of Dynamic Function in Human Stem Cell Derived β Cells. Stem Cell Reports 12, 351–365. Read more >

Ghiasi, S. M. et al. (2019) Endoplasmic reticulum chaperone glucose-regulated protein 94 is essential for proinsulin handling. Diabetes 68, 747–760. Read more >